Vietnam Interventional Cardiology Market – Industry Trends and Forecast to 2031

Análisis y tamaño del mercado de cardiología intervencionista de Vietnam

La alta prevalencia de enfermedades cardiovasculares y la creciente población geriátrica en todo el mundo contribuyen al crecimiento del mercado de la cardiología intervencionista. Sin embargo, el alto costo puede obstaculizar el crecimiento del mercado. Se espera que el aumento del gasto en atención médica actúe como una oportunidad para aumentar la demanda de dispositivos de cardiología intervencionista en el mercado. Se espera que el bajo conocimiento de la ECV y sus intervenciones desafíe el crecimiento del mercado de la cardiología intervencionista. 

Data Bridge Market Research analiza que el mercado de cardiología intervencionista de Vietnam, que fue de USD 54,77 millones en 2023, es probable que alcance los USD 92,70 millones para 2031 y se espera que experimente una CAGR del 6,80% durante el período de pronóstico 2024-2031. Los "catéteres" dominan el segmento de productos del mercado de cardiología intervencionista porque estos catéteres se utilizan en procedimientos de diagnóstico y tratamiento y, por lo tanto, tienen una alta tasa de consumo y uso. Además de los conocimientos sobre escenarios de mercado como el valor de mercado, la tasa de crecimiento, la segmentación, la cobertura geográfica y los principales actores, los informes de mercado seleccionados por Data Bridge Market Research también incluyen un análisis profundo de expertos, epidemiología del paciente, análisis de la cartera, análisis de precios y marco regulatorio.

Alcance del informe y segmentación del mercado

Definición de mercado

La cardiología intervencionista es un campo de la cardiología en el que se utilizan catéteres para diagnosticar y tratar enfermedades cardíacas. El catéter utilizado en cardiología intervencionista es un instrumento largo, tubular y flexible que se inserta a través de los vasos sanguíneos de la arteria radial del brazo, la arteria femoral de la ingle o el cuello y se enhebra hasta el corazón. A través de él, se puede evaluar el estado cardíaco de una persona, se puede reparar una válvula cardíaca dañada o se puede destapar una arteria obstruida. Algunos procedimientos de cardiología intervencionista incluyen cateterismo cardíaco, angioplastia coronaria, valvuloplastia con balón, trombectomía coronaria y ablación cardíaca.            

Dinámica del mercado de cardiología intervencionista

Conductores

• Aumento de la carga de enfermedades cardiovasculares 

La creciente incidencia de enfermedades cardiovasculares (ECV) en Vietnam es un factor importante para el mercado de la cardiología intervencionista. Factores como los cambios en los estilos de vida, los hábitos alimentarios y el envejecimiento de la población contribuyen a la mayor prevalencia de ECV. Esto impulsa la demanda de procedimientos de cardiología intervencionista, incluidas la angioplastia y la colocación de stents.

• Avances en la tecnología médica

Los avances tecnológicos en cardiología intervencionista, incluido el desarrollo de dispositivos innovadores, técnicas de cateterización mejoradas y procedimientos mínimamente invasivos, han hecho que los tratamientos sean más eficaces y seguros. Estas innovaciones atraen tanto a pacientes como a proveedores de atención médica e impulsan el crecimiento del mercado.

• Iniciativas gubernamentales e inversiones en atención sanitaria

Government initiatives and investments in the healthcare sector play a vital role in supporting the growth of interventional cardiology in Vietnam. Increased funding for healthcare infrastructure, training programs for medical professionals, and efforts to expand access to advanced cardiac care facilities contribute to market expansion.

• Growing investment for healthcare facilities

Surging focus towards improving the condition of healthcare facilities and improving the overall healthcare infrastructure another important factor fostering the growth of the market. Rising number of partnerships and strategic collaborations between the public and private players pertaining to funding and application of new and improved technology is further creating lucrative market opportunities.  

Opportunities

• Rising Demand for Minimally Invasive Procedures

There is a growing preference for minimally invasive procedures in Vietnam, which offer shorter recovery times, reduced hospital stays, and less discomfort for patients. This trend provides an opportunity for interventional cardiology providers to offer a range of minimally invasive treatments, such as angioplasty and transcatheter aortic valve replacement (TAVR), to meet the rising demand.

• Collaboration with Pharmaceutical Companies

Collaboration between interventional cardiology providers and pharmaceutical companies can lead to the development of comprehensive treatment approaches for cardiovascular diseases. This includes combining interventional procedures with pharmaceutical interventions, providing a holistic approach to patient care, and offering opportunities for market expansion.

Restraints

• Limited Access to Specialized care

In Vietnam, access to specialized interventional cardiology care can be limited, especially in rural areas. The concentration of advanced cardiac care facilities in urban centers creates disparities in healthcare access. This constraint can limit the reach of interventional cardiology services to a broader population.

• Cost and Affordability

The cost of interventional cardiology procedures, including the use of advanced medical devices, can be a significant barrier for many patients. The lack of widespread health insurance coverage and the out-of-pocket expenses associated with these treatments can make them unaffordable for a large portion of the population.

Challenges

• Regulatory and Reimbursement Challenges

The regulatory environment and reimbursement policies in Vietnam can pose challenges for healthcare providers in the interventional cardiology sector. Streamlining regulatory approvals and improving reimbursement processes can encourage the growth of this market.

• Healthcare Infrastructure Challenges

Although Vietnam is making investments in healthcare infrastructure, there are still challenges related to the availability of state-of-the-art equipment and facilities in some regions. This can hinder the growth of the interventional cardiology market by limiting the capacity to perform complex procedures.

This interventional cardiology market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the interventional cardiology market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

•  In February 2023, IS Medical AG launched OPN NC percutaneous transluminal coronary angioplasty (PTCA) dilatation catheter with Twin-Wall technology. The OPN NC device’s Twin-Wall design provides a high-pressure resistance with a rated burst pressure of 35 atm with low compliance
• In January 2023, The U.S. FDA approved the BioFreedom Drug Coated Coronary Stent (DCS) System P190020 from Biosensors International. The BioFreedom Drug Coated Coronary Stent System is intended to treat a narrowed blood vessel (coronary artery) caused by coronary artery disease

Vietnam Interventional Cardiology Market Scope

The interventional cardiology market is segmented on the type, product, indication, age, end user, and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

• Guidewire
• Catheters
• Coronary Stents
• Angioplasty Balloon
• Vascular Closure Device (VCD)
• Intravascular Ultrasound (IVUS)
• Hemodynamic Flow Alteration Devices
• Plague Modification Devices
• Fractional Flow Reserve (FFR)
• Accessories

Type

• Conventional
• Advanced

Indication

• Cardiac Catheterization
• Percutaneous Coronary Intervention (PCI)
• Coronary Thrombectomy
• Atherectomy
• Balloon Angioplasty
• Stent Implantation
• Hypothermia/Intra-Aortic Balloon Pump
• Patent Foramen Ovale Closure
• Others

Age

• Adult
• Geriatric
• Paediatric

End-user

• Hospitals
• Cath Laboratories
• Academic and Research Institutions
• Others

Distribution Channel

• Direct Tender
• Third party Distributor
• Retail Sales

Healthcare Infrastructure growth Installed base and New Technology Penetration

The interventional cardiology market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for interventional cardiology market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the interventional cardiology market. The data is available for historic period 2010-2020.

Competitive Landscape and Vietnam Interventional Cardiology Market Share Analysis

The interventional cardiology market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, Vietnam presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to interventional cardiology market.

Some of the major players operating in the interventional cardiology market are:

• Medtronic (Ireland)
• Teleflex Incorporated (U.S.)
• Terumo Vietnam Medical Equipment Co., Ltd (A Subsidiary of Terumo Corporation) (Japan)
• Abbott (U.S.)
• Boston Scientific Corporation (U.S.)
• B. Braun Melsungen AG (Germany)
• USM HEALTHCARE (Singapore)
• BIOTRONIK (Germany)
• Stryker (U.S.)
• Philips Electronics N.V. (A subsidiary of Koninjlkjke Philps NV) (Netherlands)
• BD (U.S.)
• Medinol Ltd. (Israel)
• AngioDynamics (U.S.)

SKU-66598